Neoadjuvant TAR-200 plus cetrelimab improves PCR in muscle-invasive bladder cancer
Neoadjuvant TAR-200 plus cetrelimab improves PCR in muscle-invasive bladder cancer
MCED blood test demonstrates high specificity, strong predictive value, and increased early cancer detection
Enhancing breast cancer care through AI and collaboration
ASCO 2025: Update on blood-based cancer assays
A conversational artificial intelligence system enhances precision medicine and health equity
Exploring colorectal cancer in Hispanic/Latino populations through multi-omics analysis of MYC gene and WNT signalling pathway alteration
Digital pathology superior to manual SP263 PD-L1 TC scoring for stage II-IIIA high PD-L1 expression NSCLC
Consolidation durvalumab after cCRT shows decreased disease progression in LS-SCLC
Boost IORT in breast cancer: Peruvian experience
Intraoperative radiotherapy for brain tumours
Mobile prostate cancer screening clinic can help address barriers to serving high-risk communities
SIOG 2024: Updates in radiation oncology